glp 1 from china Ozempic craze hits as first GLP-1 weight-loss drug is greenlighted – The China Project GLP-1 Medications Are Revolutionizing Healthcare

Also diabetic never-incretin-users had a worse prognosis as compared to diabetic current-incretin-users (6 months, GLP-1 agonists or DPP-4 inhibitors)

Evidence-based treatments focus on improving function, reducing pain, and enhancing quality of life rather than seeking a cure, as fibromyalgia is a chronic condition requiring long-term management strategies

Literature / References M.E

The FDA prescribing information for tirzepatide provides specific guidance for resuming treatment after a missed dose

Medicare Data (2025): Once-weekly GLP-1 RAs (especially semaglutide) showed superior MACE reduction compared to SGLT2 inhibitors in Medicare beneficiaries with atherosclerotic cardiovascular disease (ASCVD)